-

Shareholder Alert: Robbins LLP Reminds Investors It Is Investigating CURO Group Holdings Corp. (CURO)

SAN DIEGO & WICHITA, Kan.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating whether the officers and directors of CURO Group Holdings Corp. (NYSE: CURO) violated the Securities Exchange Act of 1934 between April 27, 2018 and October 24, 2018, and in so doing breached their fiduciary duties to the Company and its shareholders. CURO provides consumer finance to a range of underbanked consumers in the United States, Canada, and the United Kingdom.

If you suffered a loss as a result of CURO's misconduct, click here.

CURO Group Holdings Corp. (CURO) May Have Misled Shareholders

In response to a change in Canadian laws, CURO began to develop a strategy to transition its Canadian business out of single-pay loans to installment and line of credit ("open-end") loan products. CURO assured the transition would be slow with minimal negative impact confined to the second quarter 2018. Though CURO consistently reaffirmed its full year 2018 ("FY18") financial guidance in its public statements, on October 24, 2018, CURO announced dismal third quarter 2018 results that widely missed analysts' expectations and revealed a staggering decline of 50% year-over-year in single-pay loan balances, culminating in a significant cut to the Company's FY18 guidance. On this news, CURO's stock price fell almost 34% to close at $15.12 per share. The stock has since continued to decline, currently trading at around $8.

CURO Group Holdings Corp. (CURO) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against CURO settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:CURO

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Ostin Technology Group Co., Ltd. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ostin Technology Group Co., Ltd. (NASDAQ: OST) ordinary shares between May 11, 2025 and June 26, 2025. Ostin purports to be a manufacturer of thin-film transistor liquid crystal display modules and polarizers used in consumer electronics, commercial LCD displays, and automotive displays. For more information, submit a form, email attorney Aaro...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the REGENXBIO, Inc. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800)...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...
Back to Newsroom